- Presentations
- 2
- Markets
- 1
Ultomiris is a brand of Ravulizumab marketed by Alexion Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ravulizumab
- Brand owner
- Alexion Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 1100 mg/11 mL injection, 300 mg/3 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ultomiris 1100 mg/11 mL injectionIntravenous Cold chain | Alexion Pharmaceuticals | US FDA | Available on request |
| Ultomiris 300 mg/3 mL injectionIntravenous Cold chain | Alexion Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ultomiris
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.